Sunshine Biopharma (SBFM) Return on Capital Employed Growth (3y) (2019 - 2026)
Sunshine Biopharma (SBFM) Return on Capital Employed Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 1,301.00 |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 331.00 |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -667.00 |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 480.00 |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -254.00 |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 1,342.00 |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 1,902.00 |
| 10 | Sunshine Biopharma | 750,608.81 | -6.16 Mn | 2.18 Mn | 10,279.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,279.00 |
| Dec 31, 2025 | 7,043.00 |
| Sep 30, 2025 | -1,626.00 |
| Jun 30, 2025 | -1,621.00 |
| Mar 31, 2025 | 729.00 |
| Dec 31, 2024 | 8,390.00 |
| Sep 30, 2024 | 12,881.00 |
| Jun 30, 2024 | 15,446.00 |
| Mar 31, 2024 | 29,031.00 |
| Dec 31, 2023 | -24,965.00 |
| Sep 30, 2023 | -23,766.00 |
| Jun 30, 2023 | -24,474.00 |
| Mar 31, 2023 | -21,073.00 |
| Dec 31, 2022 | -18,622.00 |
| Sep 30, 2022 | -7,981.00 |
| Jun 30, 2022 | -26,063.00 |
| Mar 31, 2022 | 144,316.00 |
| Dec 31, 2021 | 44,599.00 |
| Sep 30, 2021 | 15,873.00 |
| Jun 30, 2021 | -220,081.00 |